Who owns fisher scientific

Flux Instruments. January 17, February 12, March 16, Intrinsic Bioprobes inc. Abizar Lakdawalla. Aditya Maheshwari. Adrienne Ferrari. Agnieszka Bebel. Akash Chodavarapu. Alejandro Antonio Manzo. Alex Karassavidis. Alexander Lavery. Alexander Smith. Alfonso Troyano. Thermo Fisher Scientific. Overview Issues Contributors Activity. Table: Acquisitions.

Further reading. Documentaries, videos and podcasts. Aquired organization. Alfa Aesar. June 25, March 6, CRS Robotics. May 1, EGS Gauging. FEI Company. May 27, July 16, FInnzymes Oy. May 3, Already an ACS Member? Choose the membership that is right for you. Discount will be applied automatically at checkout. Your account has been created successfully, and a confirmation email is on the way. Most Popular in Business Is ammonia the fuel of the future? What is hand sanitizer, and does it keep your hands germ-free?

The transaction is expected to close in the fourth quarter of this year. The companies say their strengths complement each other's. Thermo has a strong position in laboratory equipment, instrumentation, and software, while Fisher is a leader in the reagents and consumables used in such equipment and in laboratory services.

Lai, a stock analyst at the investment firm Robert W. The deal is being handled as a stock swap, with Fisher shareholders receiving two shares of Thermo common stock for each share of Fisher stock. Marijn E. Paul M. Meister, vice chairman of the board of Fisher, will become the chairman of the new company.

The board of the new company will have eight members, five nominated by Thermo and three by Fisher. Montrone, current chairman and CEO of Fisher, will step aside after the merger is complete, but he will remain as an adviser to the company. By using our services, you agree to our use of cookies. Namespaces Home Page Discussion. Views Read View source View history Help. Fisher Scientific International Inc.

Headed by Henley President Paul M. Montrone, the new company issued stock in an initial public offering, and the shares were listed on the New York Stock Exchange. The restoration of Fisher's independence set the stage for a resurgence of rapid growth. Fisher acquires Curtin Matheson Scientific. The purchase of this major provider of diagnostic products greatly expanded Fisher's participation in the clinical-laboratory market in the United States and resulted in the formation of Houston-based Fisher HealthCare.

Fisher recapitalized with investment group. Following an unsolicited takeover bid for the company, Fisher recapitalized with Thomas H. The company acquires three businesses in , increasing to 30 the total number of acquisitions since , and expanding the company's capabilities and global position. These acquisitions included Cole-Parmer Instrument Company and the pharmaceutical packaging business that is now known as Fisher Clinical Services.

The company celebrates the beginning of its second century. During its centennial, Fisher acquired three more businesses, which enhanced its European presence and expanded its chemicals products and its services for drug discovery. Fisher significantly expands its service to the world's life-science and biotechnology industries by acquiring Perbio Science AB, based in Stockholm. The transaction accelerated Fisher's growth in , and Perbio's highly regarded technology, products and services are expected to be a leading contributor to Fisher's future development.

During , Fisher greatly enhanced its position in the high-growth life-science market.